Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization
The results of two consecutive multicenter clinical trials enrolled 241 patient with childhood mature B-cells non-Hodgkin lymphomas/leukemia are presented. Patients received treatment according B-NHL 2004mab protocol (n = 83) and B-NHL 2010M (n = 158) with combined immunochemotherapy (ICT) in Russia...
Saved in:
| Main Authors: | N. V. Smirnova, N. V. Myakova, M. B. Belogurova, O. V. Ryskal, O. E. Nikonova, G. R. Sharapova, A. S. Fedorova, N. A. Grigorieva, A. V. Shamardina, N. I. Ponomareva, D. S. Abramov, D. M. Konovalov, M. E. Dubrovina, A. A. Maschan, E. V. Samochatova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2015-12-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/163 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR (ACELLBIA®) IN RHEUMATOID ARTHRITIS AS THE FIRST BIOLOGICAL AGENT: RESULTS OF PHASE III (ALTERRA) CLINICAL TRIAL
by: E. L. Nasonov, et al.
Published: (2017-09-01) -
Acellbia® and Mabtera® are recognize CD20-positive cells with equal efficiency
by: V. A. Misyurin, et al.
Published: (2015-12-01) -
Paraneoplastic pemphigus - a rare autoimmune complication in patients with chronic lymphocytic leukemia
by: M. A. Volkova, et al.
Published: (2022-11-01) -
Immediate side effects study of locally manufactured filgrastim («Leucostim®») in neutropenia treatment and prophylactics in children
by: N. Yu. Shipovskaya, et al.
Published: (2022-11-01) -
Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities
by: I. A. Demina, et al.
Published: (2017-04-01)